Business & Industry

Heads to Chongqing for its 93rd edition API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd edition at the Chongqing International Expo Center from 12–14 November 2025. Held twice annually, the event is one of the largest gatherings...

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global...

As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy environment can very well soon stabilize for many Big Pharma companies. All this puts...

It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to broaden their manufacturing presence in the U.S. so as to lessen the supply chain...

As originally reported by the Straits Times and also shared by Reuters, the enforcement of US tariffs on pharma exports from Singapore is being deferred so as to provide stakeholders ample time to work out an amicable deal with the US...

Nabla Bio, the U.S. biotech firm, said on October 14, 2025, that it has signed a second major research partnership along with Takeda Pharmaceutical, the Japanese drugmaker, thereby deepening their usage of AI in drug development. As per the new...

AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the advantages of patients across the U.S. as well as around the world. This $445 million...